Cat. No. 2094
Alternative Names: Glucagon (1-37), Enteroglucagon
Biological ActivityEndogenous glucagon-like peptide that modulates feeding and metabolism; secreted by intestinal L-cells. Increases cAMP production and inhibits gastric acid secretion in rat stomach. Also inhibits intestinal glucose absorption. Reduces fasting ghrelin levels following peripheral administration and reduces food intake and weight gain in rats following central or peripheral administration in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Dakin et al (2004) Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145 2687. PMID: 15001546.
Stanley et al (2004) Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am.J.Physiol.Gastrointest.Liver Physiol. 286 G693. PMID: 15068960.
Stumpel et al (1997) A new role for enteric glucagon-37: acute stimulation of glucose absorption in rat small intestine. FEBS Lett. 410 515. PMID: 9237694.
Bataille et al (1981) Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities. Peptides 2 41. PMID: 6283496.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Oxyntomodulin from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Oxyntomodulin, supplier, Endogenous, gut, peptide, modulates, feeding, metabolism, GLP1, Receptors, Glucagon-Like, Peptide, 1, Glucagon, Tocris Bioscience, Glucagon-Like Peptide 1 Receptor products